Cargando…

Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates

BACKGROUND: An approach to use multivalent dendrimer carriers for delivery of nucleoside signaling molecules to their cell surface G protein-coupled receptors (GPCRs) was recently introduced. RESULTS: A known adenosine receptor (AR) agonist was conjugated to polyamidoamine (PAMAM) dendrimer carriers...

Descripción completa

Detalles Bibliográficos
Autores principales: Klutz, Athena M, Gao, Zhan-Guo, Lloyd, John, Shainberg, Asher, Jacobson, Kenneth A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582240/
https://www.ncbi.nlm.nih.gov/pubmed/18947419
http://dx.doi.org/10.1186/1477-3155-6-12
_version_ 1782160660934688768
author Klutz, Athena M
Gao, Zhan-Guo
Lloyd, John
Shainberg, Asher
Jacobson, Kenneth A
author_facet Klutz, Athena M
Gao, Zhan-Guo
Lloyd, John
Shainberg, Asher
Jacobson, Kenneth A
author_sort Klutz, Athena M
collection PubMed
description BACKGROUND: An approach to use multivalent dendrimer carriers for delivery of nucleoside signaling molecules to their cell surface G protein-coupled receptors (GPCRs) was recently introduced. RESULTS: A known adenosine receptor (AR) agonist was conjugated to polyamidoamine (PAMAM) dendrimer carriers for delivery of the intact covalent conjugate to on the cell surface. Depending on the linking moiety, multivalent conjugates of the N(6)-chain elongated functionalized congener ADAC (N(6)-[4-[[[4-[[[(2-aminoethyl)amino]carbonyl]methyl]anilino]carbonyl]methyl]phenyl]-adenosine) achieved unanticipated high selectivity in binding to the cytoprotective human A(3 )AR, a class A GPCR. The key to this selectivity of > 100-fold in both radioreceptor binding (K(i app )= 2.4 nM) and functional assays (EC(50 )= 1.6 nM in inhibition of adenylate cyclase) was maintaining a free amino group (secondary) in an amide-linked chain. Attachment of neutral amide-linked chains or thiourea-containing chains preserved the moderate affinity and efficacy at the A(1 )AR subtype, but there was no selectivity for the A(3 )AR. Since residual amino groups on dendrimers are associated with cytotoxicity, the unreacted terminal positions of this A(3 )AR-selective G2.5 dendrimer were present as carboxylate groups, which had the further benefit of increasing water-solubility. The A(3 )AR selective G2.5 dendrimer was also visualized binding the membrane of cells expressing the A(3 )receptor but did not bind cells that did not express the receptor. CONCLUSION: This is the first example showing that it is feasible to modulate and even enhance the pharmacological profile of a ligand of a GPCR based on conjugation to a nanocarrier and the precise structure of the linking group, which was designed to interact with distal extracellular regions of the 7 transmembrane-spanning receptor. This ligand tool can now be used in pharmacological models of tissue rescue from ischemia and to probe the existence of A(3 )AR dimers.
format Text
id pubmed-2582240
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25822402008-11-12 Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates Klutz, Athena M Gao, Zhan-Guo Lloyd, John Shainberg, Asher Jacobson, Kenneth A J Nanobiotechnology Research BACKGROUND: An approach to use multivalent dendrimer carriers for delivery of nucleoside signaling molecules to their cell surface G protein-coupled receptors (GPCRs) was recently introduced. RESULTS: A known adenosine receptor (AR) agonist was conjugated to polyamidoamine (PAMAM) dendrimer carriers for delivery of the intact covalent conjugate to on the cell surface. Depending on the linking moiety, multivalent conjugates of the N(6)-chain elongated functionalized congener ADAC (N(6)-[4-[[[4-[[[(2-aminoethyl)amino]carbonyl]methyl]anilino]carbonyl]methyl]phenyl]-adenosine) achieved unanticipated high selectivity in binding to the cytoprotective human A(3 )AR, a class A GPCR. The key to this selectivity of > 100-fold in both radioreceptor binding (K(i app )= 2.4 nM) and functional assays (EC(50 )= 1.6 nM in inhibition of adenylate cyclase) was maintaining a free amino group (secondary) in an amide-linked chain. Attachment of neutral amide-linked chains or thiourea-containing chains preserved the moderate affinity and efficacy at the A(1 )AR subtype, but there was no selectivity for the A(3 )AR. Since residual amino groups on dendrimers are associated with cytotoxicity, the unreacted terminal positions of this A(3 )AR-selective G2.5 dendrimer were present as carboxylate groups, which had the further benefit of increasing water-solubility. The A(3 )AR selective G2.5 dendrimer was also visualized binding the membrane of cells expressing the A(3 )receptor but did not bind cells that did not express the receptor. CONCLUSION: This is the first example showing that it is feasible to modulate and even enhance the pharmacological profile of a ligand of a GPCR based on conjugation to a nanocarrier and the precise structure of the linking group, which was designed to interact with distal extracellular regions of the 7 transmembrane-spanning receptor. This ligand tool can now be used in pharmacological models of tissue rescue from ischemia and to probe the existence of A(3 )AR dimers. BioMed Central 2008-10-23 /pmc/articles/PMC2582240/ /pubmed/18947419 http://dx.doi.org/10.1186/1477-3155-6-12 Text en Copyright © 2008 Klutz et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Klutz, Athena M
Gao, Zhan-Guo
Lloyd, John
Shainberg, Asher
Jacobson, Kenneth A
Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_full Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_fullStr Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_full_unstemmed Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_short Enhanced A(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
title_sort enhanced a(3 )adenosine receptor selectivity of multivalent nucleoside-dendrimer conjugates
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2582240/
https://www.ncbi.nlm.nih.gov/pubmed/18947419
http://dx.doi.org/10.1186/1477-3155-6-12
work_keys_str_mv AT klutzathenam enhanceda3adenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates
AT gaozhanguo enhanceda3adenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates
AT lloydjohn enhanceda3adenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates
AT shainbergasher enhanceda3adenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates
AT jacobsonkennetha enhanceda3adenosinereceptorselectivityofmultivalentnucleosidedendrimerconjugates